<p>巴港財富管理在第三季度將其在強生（NYSE:JNJ - 免費報告）股票中的持倉降低了 5.1%，根據其最近向 SEC 提交的 13F 文件。該公司在季度內出售了 11,018 股後，持有 206,778 股強生的股票。強生約佔巴港財富管理持有資產的 2.3%，是其第七大持倉。巴港財富管理在強生的持倉在最近一個季度末的價值為 38,341,000 美元。</p>
<p>獲取 <strong>強生</strong> 的提醒：</p>
<ul>
<li>降息使這三隻收益 ETF 比以往更具吸引力</li>
</ul>
<p>其他一些對沖基金和機構投資者最近也買賣了該公司的股票。Clark Asset Management LLC 在第二季度將其在強生的股份增加了 51.6%。Clark Asset Management LLC 現在擁有 8,884 股強生的股票，價值 1,357,000 美元，此前在該期間內又購買了 3,025 股。北卡羅來納州財政部長在第二季度將其在強生的股份提高了 8.3%。北卡羅來納州財政部長現在擁有 1,234,945 股強生的股票，價值 188,638,000 美元，此前在上個季度又收購了 94,957 股。Avanza Fonder AB 在第二季度將其在強生的持倉增加了 2.9%。Avanza Fonder AB 現在擁有 234,647 股強生的股票，價值 35,842,000 美元，此前在上個季度又購買了 6,566 股。Talbot Financial LLC 在第三季度將其在強生的股份增加了 4.6%。Talbot Financial LLC 現在擁有 138,424 股強生的股票，價值 25,667,000 美元，此前在上個季度又購買了 6,143 股。最後，Winnow Wealth LLC 在第二季度購買了強生的新股份，價值約 295,000 美元。69.55% 的股票由機構投資者和對沖基金持有。</p>
<h2>分析師升級和降級</h2>
<p>一些分析師最近對 JNJ 股票發表了看法。華爾街禪在 9 月 13 日的研究報告中將強生的股票評級從 “持有” 上調至 “買入”。瑞銀集團在 10 月 14 日的研究報告中將強生的股票目標價從 190.00 美元提高至 214.00 美元，並給予該公司 “買入” 評級。Cowen 在 10 月 14 日的報告中重新發布了對強生股票的 “買入” 評級。加拿大皇家銀行在 12 月 17 日的研究報告中為強生股票設定了 240.00 美元的目標價。最後，Stifel Nicolaus 在 10 月 15 日的研究報告中將強生股票的目標價從 165.00 美元提高至 190.00 美元，並給予該股票 “持有” 評級。四位股票研究分析師對該股票給予了強烈買入評級，十四位給予了買入評級，九位給予了持有評級。根據 MarketBeat.com 的數據，該股票目前的平均評級為 “適度買入”，平均目標價為 210.25 美元。</p>
<ul>
<li>輝瑞加大對減肥藥物的投資</li>
</ul>
<p><strong>閲讀我們關於 JNJ 的最新報告</strong></p>
<h2>強生股票下跌 0.1%</h2>
<p>強生（NYSE:JNJ）股票在週五開盤時為 207.54 美元。該公司的 50 日移動平均線為 199.67 美元，200 日移動平均線為 180.86 美元。該公司的債務與股本比率為 0.50，速動比率為 0.80，流動比率為 1.07。強生的 1 年最低價為 140.68 美元，1 年最高價為 215.18 美元。該股票的市值為 5000.2 億美元，市盈率為 20.03，市盈增長比率為 2.25，貝塔值為 0.36。</p>
<ul>
<li>5 個醫療保健公司值得關注，因為行業輪動正在全面展開</li>
</ul>
<p>強生（NYSE:JNJ - 獲取免費報告）最近一次公佈季度財報是在 8 月 30 日，報告每股收益為 2.26 美元。該公司在該季度的收入為 240.2 億美元。強生的淨利潤率為 27.26%，股本回報率為 32.73%。股票分析師預計強生在當前年度的每股收益將達到 10.58 美元。</p>
<h2>強生宣佈分紅</h2>
<p>該公司最近還宣佈了季度分紅，已於 12 月 9 日支付。11 月 25 日的股東獲得了每股 1.30 美元的分紅。這相當於年化分紅 5.20 美元，分紅收益率為 2.5%。除息日期為 11 月 25 日。強生的分紅支付比率目前為 50.19%。</p>
<h2>強生公司簡介</h2>
<p>（免費報告）</p>
<p>強生是一家總部位於新澤西州新布倫瑞克的跨國醫療保健公司，開發、製造和銷售廣泛的產品，涵蓋製藥、醫療設備和以前的消費健康產品。該公司由約翰遜家族於 1886 年創立，已發展成為一個全球醫療保健組織，在世界許多國家開展業務和銷售。</p>
<p>該公司的製藥業務主要在其揚森研究與開發組織下運作，專注於免疫學、傳染病、腫瘤學和神經科學等治療領域的處方藥。</p>
<h2>進一步閲讀</h2>
<ul>
<li>五隻我們更看好的股票比強生更具吸引力</li>
<li>請勿刪除，立即閲讀</li>
<li>投資者提醒：微型 “3 美元人工智能奇蹟股票” 即將爆發</li>
<li>資本利得税是否可以扣除任何費用？</li>
<li>你知道亞馬遜計劃在 1 月 1 日做什麼嗎？</li>
<li>巴菲特、蓋茨和貝索斯悄悄拋售股票——原因在這裏</li>
</ul>
<p><strong>想看看其他對沖基金持有的 JNJ 嗎？</strong> 訪問 HoldingsChannel.com 獲取強生（NYSE:JNJ - 免費報告）的最新 13F 文件和內部交易。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUpOSg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUpOSg"/></p>
<p><em>此即時新聞提醒由敍事科學技術和來自 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
<h2>你現在應該投資 1,000 美元在強生嗎？</h2>
<p>在考慮強生之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而強生並不在名單上。</p>
<p>雖然強生目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

強生

<p>巴港財富管理在第三季度減少了對強生的持股比例，下降了 5.1%，出售了 11,018 股，目前持有 206,778 股，市值為 3,834 萬美元。強生在他們的投資組合中佔比 2.3%。其他投資者也調整了他們的強生持股，分析師給予 “適度買入” 的評級，目標價為 210.25 美元。強生的股票開盤價為 207.54 美元，市值為 5000.2 億美元</p>

<p>Bar Harbor Wealth Management lowered its position in shares of Johnson &amp; Johnson (NYSE:JNJ - Free Report) by 5.1% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 206,778 shares of the company's stock after selling 11,018 shares during the quarter. Johnson &amp; Johnson comprises approximately 2.3% of Bar Harbor Wealth Management's holdings, making the stock its 7th largest holding. Bar Harbor Wealth Management's holdings in Johnson &amp; Johnson were worth $38,341,000 at the end of the most recent quarter.</p>
<div class="lb-trans"><p>巴港財富管理在第三季度將其在強生（NYSE:JNJ - 免費報告）股票中的持倉降低了 5.1%，根據其最近向 SEC 提交的 13F 文件。該公司在季度內出售了 11,018 股後，持有 206,778 股強生的股票。強生約佔巴港財富管理持有資產的 2.3%，是其第七大持倉。巴港財富管理在強生的持倉在最近一個季度末的價值為 38,341,000 美元。</p>
</div><p>Get <strong>Johnson &amp; Johnson</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>強生</strong> 的提醒：</p>
</div><ul>
<li>Rate Cuts Make These 3 Income ETFs More Attractive Than Ever</li>
</ul>
<div class="lb-trans"><ul>
<li>降息使這三隻收益 ETF 比以往更具吸引力</li>
</ul>
</div><p>A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Clark Asset Management LLC increased its stake in Johnson &amp; Johnson by 51.6% during the 2nd quarter. Clark Asset Management LLC now owns 8,884 shares of the company's stock worth $1,357,000 after buying an additional 3,025 shares during the period. Treasurer of the State of North Carolina lifted its stake in shares of Johnson &amp; Johnson by 8.3% in the second quarter. Treasurer of the State of North Carolina now owns 1,234,945 shares of the company's stock worth $188,638,000 after acquiring an additional 94,957 shares in the last quarter. Avanza Fonder AB boosted its holdings in Johnson &amp; Johnson by 2.9% in the second quarter. Avanza Fonder AB now owns 234,647 shares of the company's stock valued at $35,842,000 after purchasing an additional 6,566 shares during the last quarter. Talbot Financial LLC grew its stake in Johnson &amp; Johnson by 4.6% during the 3rd quarter. Talbot Financial LLC now owns 138,424 shares of the company's stock valued at $25,667,000 after purchasing an additional 6,143 shares in the last quarter. Finally, Winnow Wealth LLC purchased a new stake in Johnson &amp; Johnson during the 2nd quarter worth approximately $295,000. 69.55% of the stock is owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>其他一些對沖基金和機構投資者最近也買賣了該公司的股票。Clark Asset Management LLC 在第二季度將其在強生的股份增加了 51.6%。Clark Asset Management LLC 現在擁有 8,884 股強生的股票，價值 1,357,000 美元，此前在該期間內又購買了 3,025 股。北卡羅來納州財政部長在第二季度將其在強生的股份提高了 8.3%。北卡羅來納州財政部長現在擁有 1,234,945 股強生的股票，價值 188,638,000 美元，此前在上個季度又收購了 94,957 股。Avanza Fonder AB 在第二季度將其在強生的持倉增加了 2.9%。Avanza Fonder AB 現在擁有 234,647 股強生的股票，價值 35,842,000 美元，此前在上個季度又購買了 6,566 股。Talbot Financial LLC 在第三季度將其在強生的股份增加了 4.6%。Talbot Financial LLC 現在擁有 138,424 股強生的股票，價值 25,667,000 美元，此前在上個季度又購買了 6,143 股。最後，Winnow Wealth LLC 在第二季度購買了強生的新股份，價值約 295,000 美元。69.55% 的股票由機構投資者和對沖基金持有。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析師升級和降級</h2>
</div><p>A number of analysts have recently weighed in on JNJ shares. Wall Street Zen raised shares of Johnson &amp; Johnson from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a research report on Saturday, September 13th. UBS Group increased their price objective on shares of Johnson &amp; Johnson from $190.00 to $214.00 and gave the company a &#34;buy&#34; rating in a research note on Tuesday, October 14th. Cowen reissued a &#34;buy&#34; rating on shares of Johnson &amp; Johnson in a report on Tuesday, October 14th. Royal Bank Of Canada set a $240.00 target price on shares of Johnson &amp; Johnson in a research note on Wednesday, December 17th. Finally, Stifel Nicolaus increased their price target on shares of Johnson &amp; Johnson from $165.00 to $190.00 and gave the stock a &#34;hold&#34; rating in a research report on Wednesday, October 15th. Four equities research analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and nine have assigned a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of &#34;Moderate Buy&#34; and an average target price of $210.25.</p>
<div class="lb-trans"><p>一些分析師最近對 JNJ 股票發表了看法。華爾街禪在 9 月 13 日的研究報告中將強生的股票評級從 “持有” 上調至 “買入”。瑞銀集團在 10 月 14 日的研究報告中將強生的股票目標價從 190.00 美元提高至 214.00 美元，並給予該公司 “買入” 評級。Cowen 在 10 月 14 日的報告中重新發布了對強生股票的 “買入” 評級。加拿大皇家銀行在 12 月 17 日的研究報告中為強生股票設定了 240.00 美元的目標價。最後，Stifel Nicolaus 在 10 月 15 日的研究報告中將強生股票的目標價從 165.00 美元提高至 190.00 美元，並給予該股票 “持有” 評級。四位股票研究分析師對該股票給予了強烈買入評級，十四位給予了買入評級，九位給予了持有評級。根據 MarketBeat.com 的數據，該股票目前的平均評級為 “適度買入”，平均目標價為 210.25 美元。</p>
</div><ul>
<li>Pfizer Adds to Its Big Bet on Weight Loss Drugs</li>
</ul>
<div class="lb-trans"><ul>
<li>輝瑞加大對減肥藥物的投資</li>
</ul>
</div><p><strong>Read Our Latest Report on JNJ</strong></p>
<div class="lb-trans"><p><strong>閲讀我們關於 JNJ 的最新報告</strong></p>
</div><h2>Johnson &amp; Johnson Stock Down 0.1%</h2>
<div class="lb-trans"><h2>強生股票下跌 0.1%</h2>
</div><p>Shares of NYSE:JNJ opened at $207.54 on Friday. The company's fifty day moving average is $199.67 and its two-hundred day moving average is $180.86. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.80 and a current ratio of 1.07. Johnson &amp; Johnson has a 1-year low of $140.68 and a 1-year high of $215.18. The stock has a market capitalization of $500.02 billion, a price-to-earnings ratio of 20.03, a price-to-earnings-growth ratio of 2.25 and a beta of 0.36.</p>
<div class="lb-trans"><p>強生（NYSE:JNJ）股票在週五開盤時為 207.54 美元。該公司的 50 日移動平均線為 199.67 美元，200 日移動平均線為 180.86 美元。該公司的債務與股本比率為 0.50，速動比率為 0.80，流動比率為 1.07。強生的 1 年最低價為 140.68 美元，1 年最高價為 215.18 美元。該股票的市值為 5000.2 億美元，市盈率為 20.03，市盈增長比率為 2.25，貝塔值為 0.36。</p>
</div><ul>
<li>5 Healthcare Names to Watch as Sector Rotation Is in Full Swing</li>
</ul>
<div class="lb-trans"><ul>
<li>5 個醫療保健公司值得關注，因為行業輪動正在全面展開</li>
</ul>
</div><p>Johnson &amp; Johnson (NYSE:JNJ - Get Free Report) last announced its quarterly earnings data on Wednesday, August 30th. The company reported $2.26 earnings per share for the quarter. The business had revenue of $24.02 billion during the quarter. Johnson &amp; Johnson had a net margin of 27.26% and a return on equity of 32.73%. Equities analysts anticipate that Johnson &amp; Johnson will post 10.58 EPS for the current year.</p>
<div class="lb-trans"><p>強生（NYSE:JNJ - 獲取免費報告）最近一次公佈季度財報是在 8 月 30 日，報告每股收益為 2.26 美元。該公司在該季度的收入為 240.2 億美元。強生的淨利潤率為 27.26%，股本回報率為 32.73%。股票分析師預計強生在當前年度的每股收益將達到 10.58 美元。</p>
</div><h2>Johnson &amp; Johnson Announces Dividend</h2>
<div class="lb-trans"><h2>強生宣佈分紅</h2>
</div><p>The business also recently declared a quarterly dividend, which was paid on Tuesday, December 9th. Stockholders of record on Tuesday, November 25th were given a dividend of $1.30 per share. This represents a $5.20 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date was Tuesday, November 25th. Johnson &amp; Johnson's dividend payout ratio is presently 50.19%.</p>
<div class="lb-trans"><p>該公司最近還宣佈了季度分紅，已於 12 月 9 日支付。11 月 25 日的股東獲得了每股 1.30 美元的分紅。這相當於年化分紅 5.20 美元，分紅收益率為 2.5%。除息日期為 11 月 25 日。強生的分紅支付比率目前為 50.19%。</p>
</div><h2>Johnson &amp; Johnson Company Profile</h2>
<div class="lb-trans"><h2>強生公司簡介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免費報告）</p>
</div><p>Johnson &amp; Johnson is a multinational healthcare company headquartered in New Brunswick, New Jersey, that develops, manufactures and markets a broad range of products across pharmaceuticals, medical devices and previously consumer health. Founded in 1886 by the Johnson family, the company has grown into a global healthcare organization with operations and sales in many countries around the world.</p>
<div class="lb-trans"><p>強生是一家總部位於新澤西州新布倫瑞克的跨國醫療保健公司，開發、製造和銷售廣泛的產品，涵蓋製藥、醫療設備和以前的消費健康產品。該公司由約翰遜家族於 1886 年創立，已發展成為一個全球醫療保健組織，在世界許多國家開展業務和銷售。</p>
</div><p>The company's pharmaceuticals business, organized largely under its Janssen research and development organization, focuses on prescription medicines across therapeutic areas such as immunology, infectious disease, oncology and neuroscience.</p>
<div class="lb-trans"><p>該公司的製藥業務主要在其揚森研究與開發組織下運作，專注於免疫學、傳染病、腫瘤學和神經科學等治療領域的處方藥。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>進一步閲讀</h2>
</div><ul>
<li>Five stocks we like better than Johnson &amp; Johnson</li>
<li>Do not delete, read immediately</li>
<li>INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off</li>
<li>Can Any Expenses Be Deducted From Capital Gains Tax?</li>
<li>Do you know what Amazon is planning for January 1?</li>
<li>Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票比強生更具吸引力</li>
<li>請勿刪除，立即閲讀</li>
<li>投資者提醒：微型 “3 美元人工智能奇蹟股票” 即將爆發</li>
<li>資本利得税是否可以扣除任何費用？</li>
<li>你知道亞馬遜計劃在 1 月 1 日做什麼嗎？</li>
<li>巴菲特、蓋茨和貝索斯悄悄拋售股票——原因在這裏</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding JNJ?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Johnson &amp; Johnson (NYSE:JNJ - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他對沖基金持有的 JNJ 嗎？</strong> 訪問 HoldingsChannel.com 獲取強生（NYSE:JNJ - 免費報告）的最新 13F 文件和內部交易。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUpOSg" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=JNJ"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和來自 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Johnson &amp; Johnson Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在強生嗎？</h2>
</div><p>Before you consider Johnson &amp; Johnson, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮強生之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson &amp; Johnson wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而強生並不在名單上。</p>
</div><p>While Johnson &amp; Johnson currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然強生目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

巴爾港財富管理公司出售了 11,018 股強生公司股票 $JNJ